INSIGHTS ON QUALITY CONTROL

• cGMP Vs GMP In Cleanrooms: Understanding The Differences That Matter

  Differentiating GMP from cGMP helps facility teams design cleanrooms that meet modern contamination controls, process flows, and regulatory standards.

• Pave The Way To High Productivity With Continuous Manufacturing For Pharma

  Continuous manufacturing delivers agility and precision for pharma, combining automation, reduced manual steps, and quality control to meet regulatory and cost pressures while accelerating development.

• Nutraceutical Packaging Inspection: Challenges, Technologies, And Solutions For Supplement Manufacturers

  Advanced X-ray inspection, metal detection, and checkweighing technologies ensure fill accuracy, eliminate contaminants, and protect nutraceutical brands.

• Data Integrity In The Quality Control Lab: No Pen, No Pain

  Data integrity in pharmaceutical QC labs is critical for product safety. This webinar explores digital solutions to improve traceability, reduce paperwork, and enhance workflows.

• Good AI Practice In GxP: 4 Implications Of FDA/EMA's Joint AI Principles

  7/17/2026

  See how quality, validation, and IT teams can prepare for the next generation of AI governance in regulated manufacturing. 

• Environmental Monitoring In Advanced Therapeutic Medicinal Products Facilities

  3/5/2026

  Discover how to adapt your environmental monitoring framework to meet the distinct risk-management and regulatory needs of ATMP facility production.

• Secondary Packaging: Cartoning And Kitting With An Aggressive Timeline

  6/23/2026

  Meeting tight launch timelines requires more than speed. Smart kit design, controlled production workflows, and scalable processes come together to deliver complex packaging programs quickly.

• Detection Of Food Spoilage Organisms

  3/5/2026

  Membrane filtration offers a faster, more precise approach to detecting spoilage organisms. See how its flexibility and accuracy make it a valuable tool for improving food microbiology processes.

• 503A Vs. 503B: Turning Regulatory Complexity Into Practical Compliance

  4/20/2026

  Navigating human drug compounding requires aligning Section 503A and Section 503B operations with cGMP expectations, robust quality management systems, and standing inspection readiness.